For: | Bhangal R, Cancarevic I, Nassar M, Umar Z. Impact of erythropoietin therapy on cardiorenal syndrome: A systematic review with meta-analysis. World J Cardiol 2023; 15(5): 273-283 [PMID: 37274373 DOI: 10.4330/wjc.v15.i5.273] |
---|---|
URL: | https://www.wjgnet.com/1949-8462/full/v15/i5/273.htm |
Number | Citing Articles |
1 |
Hideki Yokoi. Renal interstitial hydrostatic pressure: a culprit of pericyte detachment in renal congestion. Hypertension Research 2024; 47(2): 553 doi: 10.1038/s41440-023-01517-2
|
2 |
Lulu Fan, Lujia Cao, Yangyan Luo, Fang Gao. Roxadustat combined with immunosuppressants for treatment of pure red cell aplasia with kidney injury. Annals of Hematology 2024; doi: 10.1007/s00277-024-06053-8
|
3 |
Xiaosheng Jin, Weijing Jin, Guoping Li, Jisheng Zheng, Xianrong Xu. Erythropoietin alleviates lung ischemia-reperfusion injury by activating the FGF23/FGFR4/ERK signaling pathway. PeerJ 2024; 12: e17123 doi: 10.7717/peerj.17123
|